Evidence relating to the elimination of leprosy disease from Jordan

2024-9-1

Validation of Sinhalese stigma assessment and reduction of impact (SARI) scale to measure stigma related to leprosy in Sri Lanka

2024-9-1

Stigma assessment and reduction in communities: Guide to engage with culture using ‘what matters most’

2024-9-1

Editor’s Choice – September 2024

2024-9-1

Unveiling the clinico-dermoscopic and histopathological correlation of histoid leprosy: A case series

2024-9-1

Participation of people with disabilities due to Leprosy, Lymphatic Filariasis (LF), and other causes in Uganda

2024-9-1

Ulcero-necrotic erythema nodosum leprosum and perforation of the palate in relapsed lepromatous leprosy: A rare challenge

2024-9-1

A rare case of pure neuritic leprosy with hereditary spherocytosis: implications for dapsone use

2024-9-1

The fight against leprosy and lessons for the future: Commemorating the 50th anniversary of the Sasakawa Health Foundation

2024-9-1

Measuring the quality of life of people with severe leprosy and lymphatic filariasis disability in India using an informal, intervention-focused, contextual, and integrated tool for NTD disability

2024-9-1

The role of neurologists in the WHO “Toward Zero Leprosy” strategy

2024-9-1

Utilization of artificial intelligence in the epidemiological analysis of leprosy in Brazil: advances and challenges

2024-9-1

An evaluation of adverse drug reactions, adherence to treatment and quality of life in patients with leprosy receiving multidrug therapy in a tertiary care teaching hospital

2024-9-1

Strategies for leprosy services in low-endemic areas and countries

2024-9-1

Leprosy presenting as acute sensory polyneuropathy

2024-8-1

Inclusion of people with disabilities due to leprosy at work through supported employment: An analysis in the context of rehabilitation

2024-7-3

Is the WHO ‘global’ rate indicator an accurate reflection of the annual leprosy-associated disability burden experienced worldwide?

2024-6-1

The impact of leprosy-related stigma and coping mechanisms of people affected: A qualitative study from a suburban area in Northern district of Gresik, Indonesia

2024-6-1

Leprous myelitis in a patient with borderline tuberculoid Hansen’s disease

2024-6-1

G6PD deficiency in childhood borderline tuberculoid leprosy: A rare case

2024-6-1

Chronic recurrent erythema nodosum due to lepromatous lymphadenitis

2024-6-1

Uncustomary and rare presentation of Hansen’s disease ‘a mimicker’ - A narrative review

2024-6-1

Editor’s Choice – June 2024

2024-6-1

Ulnar nerve abscess in lepromatous leprosy: Insights from three cases confirmed via ultrasound imaging

2024-6-1

Response to clinical, neurophysiological and histopathological profile of patients with neuropathic pain secondary to leprosy from a referral service in southeastern Brazil

2024-6-1

Lepra at one hundred years: A century of innovation and research

2024-6-1

A lower prevalence of psoriasis in patients with leprosy: an epidemiological analysis based on Poisson’s test

2024-6-1

Asymptomatic leprosy contacts present asymmetrical skin temperature in hands by infrared thermography

2024-6-1

The WHO Skin NTD mobile application – a paradigm shift in leprosy diagnosis through Artificial Intelligence?

2024-5-9

Detailed case analysis of leprosy patients from 2015–2019 in Sri Lanka: Does data quality require improvement?

2024-5-9

Integrating ‘ocular’ NTDs

2024-5-8

The leprosy endgame in Malawi: From leprosy control project to national public health resource

2024-3-1

Clofazimine in Erythema Nodosum leprosum: where do we stand?

2024-3-1

Hansen’s discovery of the Leprosy Bacillus: controversy over preventive measures in 19th Century British Colonial India

2024-3-1

An atypical case of leprosy mimicking a lichenoid eruption

2024-3-1

The epidemiology of leprosy in Karonga District, northern Malawi 1973–2023: An analysis of leprosy’s distribution, risk factors, control and decline in rural Africa

2024-3-1

Experience and evidence building on effective innovative integrated capacity strengthening - Results from the NNN Leprosy Disease Specific Working Group session 21st September 2023

2024-3-1

The impact of COVID-19 on persons affected by leprosy and leprosy control in the North and Northeast of Brazil

2024-3-1

Editor’s Choice – March 2024

2024-3-1

Announcement

2024-3-1

Health-related quality of life of children and adolescents with leprosy in a hyperendemic region, Midwest Brazil

2024-3-1

Elimination of leprosy redefined as “interruption of transmission” – still many challenges

2023-12-1

A retrospective analysis of leprosy relapse patients after treatment with WHO-MDT at a tertiary institute in South India

2023-12-1

WHO Global leprosy (Hansen’s disease) update, 2022: New paradigm – control to elimination

2023-12-1

Evaluation of skin temperature in the hands of leprosy patients to detect peripheral autonomic dysfunction, by infrared thermography

2023-12-1

Spatial analysis reveals failures in leprosy control activities in a hyperendemic city in Brazil

2023-12-1

Leprosy in Sri Lanka: Epidemiological trends between 1985–2021

2023-12-1

Leprosy capacity in health facilities and among health workers: A baseline survey in Nigeria

2023-12-1

Recent reviewers

2023-12-1

Effect of hope, spirituality and social support on quality of life among people affected by leprosy in Indonesia: A cross-sectional study

2023-12-1